Research ArticleAdult Brain
Radiomics-Based Machine Learning for Outcome Prediction in a Multicenter Phase II Study of Programmed Death-Ligand 1 Inhibition Immunotherapy for Glioblastoma
E. George, E. Flagg, K. Chang, H.X. Bai, H.J. Aerts, M. Vallières, D.A. Reardon and R.Y. Huang
American Journal of Neuroradiology May 2022, 43 (5) 675-681; DOI: https://doi.org/10.3174/ajnr.A7488
E. George
aFrom the Department of Radiology and Biomedical Imaging (E.G.), University of California San Francisco, San Francisco, California
E. Flagg
bDepartment of Radiology (E.F., R.Y.H.), Brigham and Women’s Hospital, Boston, Massachusetts
K. Chang
cMassachusetts Institute of Technology (K.C.), Cambridge, Massachusetts
H.X. Bai
dDepartment of Diagnostic Imaging (H.X.B.), Rhode Island Hospital and Warren Alpert Medical School of Brown University, Providence, Rhode Island
H.J. Aerts
eArtificial Intelligence in Medicine Program (H.J.A.), Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
fDepartments of Radiation Oncology and Radiology (H.J.A.), Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts
M. Vallières
gDepartment of Computer Science (M.V.), Université de Sherbrooke, Sherbrooke, Quebec, Canada
D.A. Reardon
hCenter for Neuro Oncology (D.A.R.), Dana-Farber Cancer Institute, Boston, Massachusetts
R.Y. Huang
bDepartment of Radiology (E.F., R.Y.H.), Brigham and Women’s Hospital, Boston, Massachusetts
References
- 1.↵
- 2.↵
- Stupp R,
- Hegi ME,
- Mason WP, et al
- 3.↵
- 4.↵
- Wainwright DA,
- Chang AL,
- Dey M, et al
- 5.↵
- 6.↵Bristol-Myers Squibb Announces Phase 3 CheckMate-498 Study Did Not Meet Primary Endpoint of Overall Survival with Opdivo (nivolumab) Plus Radiation in Patients with Newly Diagnosed MGMT-Unmethylated Glioblastoma Multiforme. https://news.bms.com/press-release/corporatefinancial-news/bristol-myers-squibb-announces-phase-3-checkmate-498-study-did. May 9, 2019. Accessed March 30, 2020
- 7.↵Bristol-Myers Squibb Provides Update on Phase 3 Opdivo (nivolumab) CheckMate-548 Trial in Patients with Newly Diagnosed MGMT-Methylated Glioblastoma Multiforme. https://news.bms.com/press-release/corporatefinancial-news/bristol-myers-squibb-provides-update-phase-3-opdivo-nivolumab-. September 5, 2019. Accessed March 30, 2020.
- 8.↵
- 9.↵
- Reardon DA,
- Kaley TJ,
- Dietrich J, et al
- 10.↵
- 11.↵
- 12.↵
- Reardon DA,
- Omuro A,
- Brandes AA, et al
- 13.↵Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma. https://clinicaltrials.gov/ct2/show/NCT02336165. Accessed February 1, 2022
- 14.↵
- Reardon DA,
- Kaley TJ,
- Dietrich J, et al
- 15.↵
- Zwanenburg A,
- Leger S,
- Vallieres M, et al
- 16.↵Documentation/Nightly/Modules/SwissSkullStripper. https://www.slicer.org/wiki/Documentation/Nightly/Modules/SwissSkullStripper. Accessed February 1, 2022
- 17.↵
- 18.↵
- 19.↵
- 20.↵A repository to develop code for IBSI compliant radiomics applications. https://github.com/mvallieres/radiomics-develop. Accessed April 26, 2020
- 21.↵
- Ishwaran H,
- Kogalur UB,
- Blackstone EH, et al
- 22.↵
- 23.↵
- Hung H,
- Chiang C
- 24.↵
- Rundo F,
- Spampinato C,
- Banna GL, et al
- 25.↵
- Jazieh K,
- Khorrami M,
- Saad AM, et al
- 26.↵
- Sforazzini F,
- Salome P,
- Kudak A, et al
- 27.↵
- 28.↵
- 29.↵
- 30.↵
- 31.↵
- 32.↵
- 33.↵
- 34.↵
- 35.↵
- Kickingereder P,
- Gotz M,
- Muschelli J, et al
- 36.↵
- Wang C,
- Sun W,
- Kirkpatrick J, et al
- 37.↵
- 38.↵
- 39.↵
- 40.↵
- 41.↵
In this issue
American Journal of Neuroradiology
Vol. 43, Issue 5
1 May 2022
Advertisement
Radiomics-Based Machine Learning for Outcome Prediction in a Multicenter Phase II Study of Programmed Death-Ligand 1 Inhibition Immunotherapy for Glioblastoma
E. George, E. Flagg, K. Chang, H.X. Bai, H.J. Aerts, M. Vallières, D.A. Reardon, R.Y. Huang
American Journal of Neuroradiology May 2022, 43 (5) 675-681; DOI: 10.3174/ajnr.A7488
Radiomics-Based Machine Learning for Outcome Prediction in a Multicenter Phase II Study of Programmed Death-Ligand 1 Inhibition Immunotherapy for Glioblastoma
E. George, E. Flagg, K. Chang, H.X. Bai, H.J. Aerts, M. Vallières, D.A. Reardon, R.Y. Huang
American Journal of Neuroradiology May 2022, 43 (5) 675-681; DOI: 10.3174/ajnr.A7488
Jump to section
Related Articles
Cited By...
This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.
- Philipp Lohmann, Enrico Franceschi, Philipp Vollmuth, Frédéric Dhermain, Michael Weller, Matthias Preusser, Marion Smits, Norbert GalldiksThe Lancet Digital Health 2022 4 11
- A. Prelaj, V. Miskovic, M. Zanitti, F. Trovo, C. Genova, G. Viscardi, S.E. Rebuzzi, L. Mazzeo, L. Provenzano, S. Kosta, M. Favali, A. Spagnoletti, L. Castelo-Branco, J. Dolezal, A.T. Pearson, G. Lo Russo, C. Proto, M. Ganzinelli, C. Giani, E. Ambrosini, S. Turajlic, L. Au, M. Koopman, S. Delaloge, J.N. Kather, F. de Braud, M.C. Garassino, G. Pentheroudakis, C. Spencer, A.L.G. PedrocchiAnnals of Oncology 2024 35 1
- Jiefeng Luo, Mika Pan, Ke Mo, Yingwei Mao, Donghua ZouSeminars in Cancer Biology 2023 91
- Nastaran Khalili, Anahita Fathi Kazerooni, Ariana Familiar, Debanjan Haldar, Adam Kraya, Jessica Foster, Mateusz Koptyra, Phillip B. Storm, Adam C. Resnick, Ali Nabavizadehnpj Precision Oncology 2023 7 1
- Anirban Das, Nicholas R. Fernandez, Adrian Levine, Vanessa Bianchi, Lucie K. Stengs, Jiil Chung, Logine Negm, Jose Rafael Dimayacyac, Yuan Chang, Liana Nobre, Ayse B. Ercan, Santiago Sanchez-Ramirez, Sumedha Sudhaman, Melissa Edwards, Valerie Larouche, David Samuel, An Van Damme, David Gass, David S. Ziegler, Stefan S. Bielack, Carl Koschmann, Shayna Zelcer, Michal Yalon-Oren, Gadi Abede Campino, Tomasz Sarosiek, Kim E. Nichols, Rebecca Loret De Mola, Kevin Bielamowicz, Magnus Sabel, Charlotta A. Frojd, Matthew D. Wood, Jason M. Glover, Yi-Yen Lee, Magimairajan Vanan, Jenny K. Adamski, Sebastien Perreault, Omar Chamdine, Magnus Aasved Hjort, Michal Zapotocky, Fernando Carceller, Erin Wright, Ivana Fedorakova, Alexander Lossos, Ryuma Tanaka, Michael Osborn, Deborah T. Blumenthal, Melyssa Aronson, Ute Bartels, Annie Huang, Vijay Ramaswamy, David Malkin, Adam Shlien, Anita Villani, Peter B. Dirks, Trevor J. Pugh, Gad Getz, Yosef E. Maruvka, Derek S. Tsang, Birgit Ertl-Wagner, Cynthia Hawkins, Eric Bouffet, Daniel A. Morgenstern, Uri TaboriCancer Discovery 2024 14 2
- Paniz Sabeghi, Paniz Zarand, Sina Zargham, Batis Golestany, Arya Shariat, Myles Chang, Evan Yang, Priya Rajagopalan, Daniel Phung, Ali GholamrezanezhadCancers 2024 16 3
- Di Chen, Rui Zhang, Xiaoming Huang, Chunxia Ji, Wei Xia, Ying Qi, Xinyu Yang, Lishuang Lin, Jing Wang, Haixia Cheng, Weijun Tang, Jinhua Yu, Dave S. B. Hoon, Jun Zhang, Xin Gao, Yu YaoBiomarker Research 2024 12 1
- Simone C. da Silva Rosa, Amir Barzegar Behrooz, Sofia Guedes, Rui Vitorino, Saeid GhavamiExpert Review of Proteomics 2024 21 4
- Masoumeh Najafi, Amin Jahanbakhshi, Sebastiano Finocchi Ghersi, Lucia Giaccherini, Andrea Botti, Francesco Cavallieri, Jessica Rossi, Federico Iori, Cinzia Iotti, Patrizia Ciammella, Mohsen Nabiuni, Marzieh Gomar, Omid Rezaie, Salvatore CozziBrain Sciences 2023 13 2
- Jiamin Chen, Daniel Rebibo, Jianquan Cao, Simon Yat-Man Mok, Neel Patel, Po-Cheng Tseng, Zhenghao Zhang, Kevin Y YipNAR Cancer 2023 5 1
More in this TOC Section
Adult Brain
Functional
Similar Articles
Advertisement